Evidence map›Paper›PMID 34938681›Full record

ArticleSouth Asian journal of cancer2021

Challenges in the Management of Lung Cancer: Real-World Experience from a Tertiary Center in South India.

Vishnu Gopal, Biswajit Dubashi, Smita Kayal, Prasanth Penumadu, Manju Rajaram, Gunaseelan Karunanithi, Subathra Adithan, Pampa Ch Toi, Prasanth Ganesan

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in South Asian journal of cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Vishnu GopalDepartment of Medical Oncology, JIPMER, Puducherry, India.
Biswajit DubashiDepartment of Medical Oncology, JIPMER, Puducherry, India.
Smita KayalDepartment of Medical Oncology, JIPMER, Puducherry, India.
Prasanth PenumaduDepartment of Medical Oncology, JIPMER, Puducherry, India.
Manju RajaramDepartment of Medical Oncology, JIPMER, Puducherry, India.
Gunaseelan KarunanithiDepartment of Medical Oncology, JIPMER, Puducherry, India.
Subathra AdithanDepartment of Medical Oncology, JIPMER, Puducherry, India.
Pampa Ch ToiDepartment of Medical Oncology, JIPMER, Puducherry, India.
Prasanth GanesanDepartment of Medical Oncology, JIPMER, Puducherry, India.
Jawaharlal Institute of Post Graduate Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is one of the most common cancers and an important cause of cancer-related mortality. Recent advances in targeted therapy and immunotherapy have improved outcomes, but these have limited penetration in resource-constrained situations. We report the real-world experience in treating patients with lung cancer in India. A retrospective analysis of baseline characters, treatment and outcomes of patients with lung cancer seen between January 2015 to December 2018 (

Indexed as

Chemotherapydelay in treatmentLung canceroutcomestargeted therapy

Identifiers

PMID34938681
PMCPMC8687871
OpenAlexW4200375003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.